SEC Form 4 reporting owner

Chen Wan-Shan

Chen Wan-Shan has filed 2 Form 4 transactions reported between March 31, 2026 and April 9, 2026, as a reporting owner of BELITE BIO, INC.

Name as filed: Chen Wan-Shan

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$198K
1 lines
Companies
1
with Form 4 filings
Latest transaction
Apr 9, 2026
transaction date

Roles and reported holdings

  • BLTEBELITE BIO, INC
    Mar 31, 2026 – Apr 9, 2026

    Reporting owner

    Held directly9,096 sh as of Apr 9, 2026 · Form 4

    24 months: $198K sold

Transaction history

All 2 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Apr 9, 2026BLTEOpen-market saleCode S · direct1,100$198K@ $180.43Form 4
Mar 31, 2026BLTEGrant or awardCode A · direct13,796—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.